European Consortium Investigating Molecular Basis of IBD | GenomeWeb

NEW YORK (GenomeWeb News) – Olink Bioscience today announced a consortium formed to advance research into inflammatory bowel diseases.

The Inflammatory Bowel Disease Characterization by a multi-modal integrated biomarker study Consortium was launched in December with a €6 million ($7.7 million) grant from the European Commission's 7th Framework Program. The effort will run through Nov. 30, 2016.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.